Parkinson Lead Lead program in Parkinson's Disease and preclinical data ready for presentation at major conferences; potential for collaboration with pharma companies pursuing neurodegenerative therapies and translational cell-based approaches.

Global Expansion Presence in France with a Boston technology hub and a Japan subsidiary; opportunity to engage regional partners and contract development/CO development deals across Europe, US, and Asia.

Financing Signals Significant recent financing including EIB investment and growth in Japan indicates strong investor confidence and financial runway for co-development partnerships and large-scale manufacturing collaborations.

C-Stem Advantage Proprietary C-Stem technology enabling scalable mass production of iPSCs and 3D microtissues; potential selling point for pharma manufacturers and bioproduction clients seeking scalable cell therapy manufacturing solutions.

Strategic Collaborations Active research partnerships with academic institutions and industry players, plus participation in high-profile conferences; leverage for joint development deals, data licensing, and early-access collaborations for new cell therapy formats.